Niagen Bioscience, Inc. NAGE
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.14% | 10.39% | 19.71% | 45.22% | 98.90% |
| Total Receivables | -24.88% | -16.34% | 64.34% | 25.40% | 13.88% |
| Inventory | 9.22% | 43.27% | 114.72% | 122.19% | 78.22% |
| Prepaid Expenses | 133.87% | 18.34% | 1.57% | -47.14% | 19.48% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.00% | 0.00% | 0.00% | 355.92% | 0.00% |
| Total Current Assets | 7.05% | 12.81% | 37.92% | 51.02% | 79.57% |
|
|
|||||
| Total Current Assets | 7.05% | 12.81% | 37.92% | 51.02% | 79.57% |
| Net Property, Plant & Equipment | -25.57% | -25.74% | -23.55% | 1.91% | 6.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1,987.80% | 1,770.07% | 1,603.42% | 1,476.60% | -38.04% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 12.71% | 0.00% | -11.35% | 15.49% | 11.50% |
| Total Assets | 10.76% | 16.46% | 40.56% | 55.84% | 73.63% |
|
|
|||||
| Total Accounts Payable | -9.72% | -31.00% | 24.88% | 26.62% | 84.59% |
| Total Accrued Expenses | -54.79% | -47.96% | -15.79% | -1.22% | -9.30% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -18.30% | -4.78% | 8.86% | 0.80% | -4.12% |
| Total Finance Division Other Current Liabilities | 130.14% | 181.52% | 331.88% | -34.70% | 58.70% |
| Total Other Current Liabilities | 130.14% | 181.52% | 331.88% | -34.70% | 58.70% |
| Total Current Liabilities | -25.56% | -32.59% | 9.54% | 10.98% | 28.32% |
|
|
|||||
| Total Current Liabilities | -25.56% | -32.59% | 9.54% | 10.98% | 28.32% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -38.47% | -39.37% | -40.06% | 9.54% | 10.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 178.05% | 184.18% | 195.89% | 215.59% | 3.68% |
| Total Liabilities | -6.71% | -11.96% | 23.11% | 34.66% | 23.97% |
|
|
|||||
| Common Stock & APIC | 0.90% | 0.99% | 3.59% | 5.73% | 7.11% |
| Retained Earnings | 6.07% | 9.23% | 10.54% | 9.56% | 10.80% |
| Treasury Stock & Other | 88.89% | 50.00% | 40.00% | -125.00% | -28.57% |
| Total Common Equity | 17.54% | 28.56% | 48.76% | 66.04% | 105.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 17.54% | 28.56% | 48.76% | 66.04% | 105.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 17.54% | 28.56% | 48.76% | 66.04% | 105.64% |
|
|
|||||